A Gel-Based Proteomic Analysis Reveals Synovial α-Enolase and Fibrinogen β-Chain Dysregulation in Knee Osteoarthritis: A Controlled Trial

Background: The identification of synovial fluid (SF) biomarkers that could anticipate the diagnosis of osteoarthritis (OA) is gaining increasing importance in orthopaedic clinical practice. This controlled trial aims to assess the differences between the SF proteome of patients affected by severe OA undergoing Total Knee Replacement (TKR) compared to control subjects (i.e., subjects younger than 35, undergoing knee arthroscopy for acute meniscus injury). Methods: The synovial samples were collected from patients with Kellgren Lawrence grade 3 and 4 knee osteoarthritis undergoing THR (study group) and young patients with meniscal tears and no OA signs undergoing arthroscopic surgery (control group). The samples were processed and analyzed following the protocol defined in our previous study. All of the patients underwent clinical evaluation using the International Knee Documentation Committee (IKDC) subjective knee evaluation (main outcome), Knee Society Clinical Rating System (KSS), Knee injury and Osteoarthritis Outcome Score (KOOS), and Visual Analogue Scale (VAS) for pain. The drugs’ assumptions and comorbidities were recorded. All patients underwent preoperative serial blood tests, including complete blood count and C-Reactive Protein (CRP). Results: The synovial samples’ analysis showed a significantly different fibrinogen beta chain (FBG) and alpha-enolase 1 (ENO1) concentration in OA compared to the control samples. A significant correlation between clinical scores, FBG, and ENO1 concentration was observed in osteoarthritic patients. Conclusions: Synovial fluid FBG and ENO1 concentrations are significantly different in patients affected by knee OA compared with non-OA subjects.

[1]  G. Banfi,et al.  The Usefulness of Synovial Fluid Proteome Analysis in Orthopaedics: Focus on Osteoarthritis and Periprosthetic Joint Infections , 2022, Journal of functional morphology and kinesiology.

[2]  X. S. Liu,et al.  Activating EGFR Signaling Attenuates Osteoarthritis Development Following Loading Injury in Mice , 2022, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  B. Moretti,et al.  Towards Precision Medicine for Osteoarthritis: Focus on the Synovial Fluid Proteome , 2022, International journal of molecular sciences.

[4]  Jingcheng Wang,et al.  Estrogen alleviates post-traumatic osteoarthritis progression and decreases p-EGFR levels in female mouse cartilage , 2022, BMC Musculoskeletal Disorders.

[5]  Peilai Liu,et al.  SIRT1 restoration enhances chondrocyte autophagy in osteoarthritis through PTEN-mediated EGFR ubiquitination , 2022, Cell death discovery.

[6]  J. de Magalhães,et al.  Identifying Novel Osteoarthritis-Associated Genes in Human Cartilage Using a Systematic Meta-Analysis and a Multi-Source Integrated Network , 2022, International journal of molecular sciences.

[7]  Jaimo Ahn,et al.  EGFR Signaling Is Required for Maintaining Adult Cartilage Homeostasis and Attenuating Osteoarthritis Progression , 2022, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  B. Moretti,et al.  Biophysical Stimulation in Athletes’ Joint Degeneration: A Narrative Review , 2021, Medicina.

[9]  A. Leithner,et al.  Fatty Acid–Binding Protein 4 (FABP4) Is Associated with Cartilage Thickness in End-Stage Knee Osteoarthritis , 2021, Cartilage.

[10]  L. Gesualdo,et al.  Beyond pre-analytical and analytical concerns in the study of synovial fluid proteome: description of an optimized Gel-based protocol. , 2021, Journal of biological regulators and homeostatic agents.

[11]  L. Levin,et al.  Targeting cartilage EGFR pathway for osteoarthritis treatment , 2021, Science Translational Medicine.

[12]  Lidong Wu,et al.  miR-7/EGFR/MEGF9 axis regulates cartilage degradation in osteoarthritis via PI3K/AKT/mTOR signaling pathway , 2021, Bioengineered.

[13]  R. Saghiri,et al.  Evaluation of autoantibodies against vimentin and α-enolase in rheumatoid arthritis patients , 2020, Reumatologia.

[14]  Kara Dolinski,et al.  The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactions , 2020, Protein science : a publication of the Protein Society.

[15]  B. Moretti,et al.  The use of a gentamicin-coated titanium nail, combined with RIA system, in the management of non-unions of open tibial fractures: A single centre prospective study. , 2020, Injury.

[16]  A. Yayon,et al.  A novel approach for knee osteoarthritis using high molecular weight hyaluronic acid conjugated to plasma fibrinogen – interim findings of a double-blind clinical study , 2020, Heliyon.

[17]  Z. Dong,et al.  Identifing the gender-specific genes and pathways in osteoarthritis by bioinfromatics , 2020 .

[18]  A. Gelber,et al.  Osteoarthritis , 2020, Annals of Internal Medicine.

[19]  L. Qin,et al.  EGFR Signaling: Friend or Foe for Cartilage? , 2019, JBMR plus.

[20]  B. Moretti,et al.  Biophysical stimulation of the knee with PEMFs: from bench to bedside. , 2018, Journal of biological regulators and homeostatic agents.

[21]  S. Lyman,et al.  What Are the Minimal and Substantial Improvements in the HOOS and KOOS and JR Versions After Total Joint Replacement? , 2018, Clinical orthopaedics and related research.

[22]  A. Stensballe,et al.  Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3 , 2018, PloS one.

[23]  H. Ozawa,et al.  Suitable reference gene selection for gene expression studies in knee osteoarthritis synovium using quantitative PCR analysis , 2018, Connective tissue research.

[24]  Tanshi Li,et al.  Proteomic analysis of synovial fluid in osteoarthritis using SWATH-mass spectrometry , 2017, Molecular medicine reports.

[25]  E. Diamandis,et al.  Synovial fluid proteomics in the pursuit of arthritis mediators: An evolving field of novel biomarker discovery , 2017, Critical reviews in clinical laboratory sciences.

[26]  A. Mobasheri,et al.  Osteoarthritis Year in Review 2016: biomarkers (biochemical markers). , 2017, Osteoarthritis and cartilage.

[27]  M. Fu,et al.  Screening of gene signatures for rheumatoid arthritis and osteoarthritis based on bioinformatics analysis , 2016, Molecular medicine reports.

[28]  T. Dwyer,et al.  Association of Body Composition and Hormonal and Inflammatory Factors With Tibial Cartilage Volume and Sex Difference in Cartilage Volume in Young Adults , 2016, Arthritis care & research.

[29]  L. Lix,et al.  Estimating the Burden of Osteoarthritis to Plan for the Future , 2015, Arthritis care & research.

[30]  A. Zonderman,et al.  Interrelationships of Sex, Physician-Diagnosed Arthritis, Chronic Inflammation, and Physical Functioning in the Third National Health and Nutrition Examination Surveys , 2015, Gerontology & geriatric medicine.

[31]  T. Vos,et al.  The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study , 2014, Annals of the rheumatic diseases.

[32]  Nandini A. Sahasrabuddhe,et al.  Proteomic analysis of human osteoarthritis synovial fluid , 2014, Clinical Proteomics.

[33]  M. Nevitt,et al.  Biomarkers for osteoarthritis: current position and steps towards further validation. , 2014, Best practice & research. Clinical rheumatology.

[34]  S. Mohan,et al.  Proteomic profiling and functional characterization of early and late shoulder osteoarthritis , 2013, Arthritis Research & Therapy.

[35]  L. Gesualdo,et al.  Association of urinary laminin G-like 3 and free K light chains with disease activity and histological injury in IgA nephropathy. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[36]  D. Saris,et al.  Interleukin-6 is elevated in synovial fluid of patients with focal cartilage defects and stimulates cartilage matrix production in an in vitro regeneration model , 2012, Arthritis Research & Therapy.

[37]  Yeong-Wook Song,et al.  α-Enolase Expressed on the Surfaces of Monocytes and Macrophages Induces Robust Synovial Inflammation in Rheumatoid Arthritis , 2012, The Journal of Immunology.

[38]  Cristina Ruiz-Romero,et al.  Osteoarthritis: Metabolomic characterization of metabolic phenotypes in OA , 2012, Nature Reviews Rheumatology.

[39]  M. Mazumdar,et al.  Factors that impact expectations before total knee arthroplasty. , 2011, The Journal of arthroplasty.

[40]  M. Capello,et al.  α‐enolase: a promising therapeutic and diagnostic tumor target , 2011, The FEBS journal.

[41]  J. Block,et al.  The role of synovial fluid markers of catabolism and anabolism in osteoarthritis, rheumatoid arthritis and asymptomatic organ donors , 2011, Arthritis Research & Therapy.

[42]  J. Katz,et al.  Synovial inflammation in patients undergoing arthroscopic meniscectomy: molecular characterization and relationship to symptoms. , 2011, Arthritis and rheumatism.

[43]  G. Belcaro,et al.  Variations in C-reactive protein, plasma free radicals and fibrinogen values in patients with osteoarthritis treated with Pycnogenol® , 2008, Redox report : communications in free radical research.

[44]  Marcus K. Taylor,et al.  Reliability and validity of the International Knee Documentation Committee (IKDC) Subjective Knee Form. , 2007, Joint, bone, spine : revue du rhumatisme.

[45]  S. Goldring,et al.  Osteoarthritis , 2007 .

[46]  G R Burmester,et al.  Association of citrullinated proteins with synovial exosomes. , 2006, Arthritis and rheumatism.

[47]  V. Pancholi,et al.  Multifunctional α-enolase: its role in diseases , 2001, Cellular and Molecular Life Sciences CMLS.

[48]  E. Girbal-Neuhauser,et al.  The Major Synovial Targets of the Rheumatoid Arthritis-Specific Antifilaggrin Autoantibodies Are Deiminated Forms of the α- and β-Chains of Fibrin1 , 2001, The Journal of Immunology.

[49]  J. Gécz,et al.  Identification of the gene (SEDL) causing X-linked spondyloepiphyseal dysplasia tarda , 1999, Nature Genetics.

[50]  L. Dorr,et al.  Rationale of the Knee Society clinical rating system. , 1989, Clinical orthopaedics and related research.

[51]  G. Zavattini,et al.  The role of biophysical stimulation with pemfs in fracture healing: from bench to bedside. , 2020, Journal of biological regulators and homeostatic agents.

[52]  R. Savino,et al.  C3f is a potential tool for the staging of osteoarthritis. , 2017, Journal of biological regulators and homeostatic agents.

[53]  S. Kaneko,et al.  Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis. , 2000, Cytokines, cellular & molecular therapy.